Nat Rev Dis primers
If you are researching before starting treatment: Semaglutide Success Stories: Starting BMI 27-30 is a manageable aspect of GLP-1 therapy that your provider can help you plan for from day one
Leading the spectrum is Wegovy, a weekly semaglutide injection implemented via a pre-filled pen, and the Wegovy oral tablet offeringfor those opting out of injections
Visual Format: Mechanism of action diagram Key Labels: GHK-Cu complex, copper ions, fibroblasts, collagen synthesis, extracellular matrix, glycosaminoglycans, inflammation pathways, wound repair Suggested Layout: Place the GHK-Cu complex in the center
Individual results vary based on starting weight, dose, diet, activity level, and other factors